Evidence map›Paper›PMID 35096100›Full record

ArticleEvidence-based complementary and alternative medicine : eCAM2022

Study on the Multitarget Mechanism and Active Compounds of Essential Oil from

Shu-Ting Lu, Lu-Lu Tang, Ling-Han Zhou, Ying-Tao Lai, Lan-Xing Liu, Yifan Duan

Open access · hybridAbstract read
In one paragraph

Article in Evidence-based complementary and alternative medicine : eCAM, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.7field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Pharmacological and bioactive properties ofFrontiers in pharmacology · 2025
    Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Shu-Ting LuThe First College of Clinical Medicine, Guangzhou University of Chinese Medicine, Guangzhou, China.ORCID https://orcid.org/0000-0001-9368-6379
Lu-Lu TangThe First College of Clinical Medicine, Guangzhou University of Chinese Medicine, Guangzhou, China.ORCID https://orcid.org/0000-0003-0214-1491
Ling-Han ZhouThe First College of Clinical Medicine, Guangzhou University of Chinese Medicine, Guangzhou, China.ORCID https://orcid.org/0000-0003-4728-4365
Ying-Tao LaiDepartment of Anesthesiology, The First Affiliated Hospital, Guangzhou University of Chinese Medicine, Guangzhou, China.ORCID https://orcid.org/0000-0002-6186-836X
Lan-Xing LiuThe First College of Clinical Medicine, Guangzhou University of Chinese Medicine, Guangzhou, China.ORCID https://orcid.org/0000-0002-1876-5074
Yifan DuanThe First College of Clinical Medicine, Guangzhou University of Chinese Medicine, Guangzhou, China.ORCID https://orcid.org/0000-0002-9219-4177
Guangzhou University of Chinese Medicine · CNFirst Affiliated Hospital of Guangzhou University of Chinese Medicine · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In order to comprehensively explore multitarget mechanism and key active compounds of

Identifiers

PMID35096100
PMCPMC8791709
OpenAlexW4205709237

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.